The Genomics Advisory Committee meets a minimum of twice per year to provide guidance regarding scientific direction and emerging technologies, facility management, fiscal operations, and future planning.
Members of the Genomics Advisory Committee are listed below and include a campus-wide representation of users and key stakeholders, including OHSU clinical and academic departments, institutes, and the Oregon National Primate Research Center. Committee members bring a range of experience in basic, translational, and clinical research, and in technology development.
|Name||Title and affiliation|
|Jeff Tyner, Ph.D. (Committee Chair)||Associate professor, Cell Development & Cancer Biology|
|Chris Corless, M.D., Ph.D.||Professor, pathology chief medical officer, Knight Diagnostic Laboratories|
|Paul Spellman, Ph.D.||Professor, Molecular & Medical Genetics co-director: CEDAR, OHSU Knight Cancer Institute|
|Soren Impey, Ph.D.||Associate professor of pediatrics, Oregon Stem Cell Center|
|Lucia Carbone, Ph.D.||Assistant professor, Division of Cardiovascular Medicine Director of Epigenetics Consortium|
|Beth Wilmot, Ph.D.||Research assistant professor, Oregon Clinical and Translational Research Institute|
|Brian O'Roak, Ph.D.||Associate professor, Molecular & Medical Genetics|
|Andrew Adey, Ph.D.||Assistant professor, Molecular & Medical Genetics|